I have a mid-20s nephew who appears to be afflicted with a severe case of failure-to-launch syndrome. He dropped out of ...
Travere’s stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.
I have a mid-20s nephew who appears to be afflicted with a severe case of failure-to-launch syndrome. He dropped out of ...
Her sister is already sensitive about her son failing to launch. How does the letter writer talk to her about it?